Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
Investment Firms›
Patient Square Capital
AddedFeb 13, 2024
UpdatedJun 28, 2026
Patient Square Capital

Patient Square Capital

Operating

Patient Square Capital: A healthcare investment firm fostering growth in health-focused organizations.

Location
Menlo Park, CA, US
Founded
2020
Firm
Compare
Portfolio
Employees
Website

Patient Square Capital is a dedicated healthcare investment firm that partners with exceptional management teams to improve health through innovative products, services, and technologies. The firm leverages extensive industry expertise, a broad network of relationships, and a partnership approach to drive growth and success in its portfolio companies. Patient Square Capital's investments span various stages, including post-IPO equity, private equity, and venture capital rounds.

Notable portfolio companies include Roivant Sciences, Kriya Therapeutics, and Liquidia Technologies. The firm's leadership brings deep experience and a multi-dimensional approach to healthcare investing. Patient Square Capital's name reflects its commitment to patient capital and patient-centric investments, emphasizing a relentless focus on long-term value creation in the healthcare sector.

Patient Square Capital - Portfolio Snapshot

Portfolio activity breakdown across disclosed investments and stages

Total Investments8
Current Portfolio Count6
Total Portfolio Exits0

Top Investment Stages

Post Ipo Equity2 (25.0%)
Private Equity2 (25.0%)
Series C2 (25.0%)
Series B1 (12.5%)
Series Unknown1 (12.5%)

Stage Mix

Post Ipo Equity 25%Private Equity 25%Series C 25%Series B 13%Series Unknown 13%

Concentration shown as share of disclosed investments by stage.

Recent Investments

Liquidia logo

Liquidia

Kriya Therapeutics logo

Kriya Therapeutics

Elevage Medical Technologies logo

Elevage Medical Technologies

Alladapt Immunotherapeutics logo

Alladapt Immunotherapeutics

Enavate Sciences logo

Enavate Sciences

Roivant Sciences logo

Roivant Sciences

Patient Square Capital - Classification

Also Known As
  • Patient Square Capital, LP
NAICS
  • 520000Finance and Insurance
  • 523000Securities, Commodity Contracts, and Other Financial Investments and Related Activities
  • 523900Other Financial Investment Activities
  • 523990All Other Financial Investment Activities
  • 523999Miscellaneous Financial Investment Activities
SIC
  • 6700Holding And Other Investment Offices
  • 6720Investment Offices
  • 6722Management Investment Offices, Open-end
Show 2 more industry codes
NAICS
  • 525000Funds, Trusts, and Other Financial Vehicles
SIC
  • 6000Depository Institutions